PBM
PBM
NASDAQ · Biotechnology

Psyence Biomedical Ltd

$2.47
-0.05 (-1.98%)
As of Mar 31, 5:01 PM ET ·
Financial Highlights (FY 2025)
Revenue
462.8K
Net Income
-17,156
Gross Margin
45.1%
Profit Margin
-3.7%
Rev Growth
+1.4%
D/E Ratio
0.29
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 45.1% 45.1% 45.1%
Operating Margin -5.5% -5.0% -5.5%
Profit Margin -3.7% -3.9% -4.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 462.8K 474.7K 442.2K
Gross Profit 208.7K 214.1K 199.4K
Operating Income -25,565 -23,943 -24,359
Net Income -17,156 -18,549 -17,491
Gross Margin 45.1% 45.1% 45.1%
Operating Margin -5.5% -5.0% -5.5%
Profit Margin -3.7% -3.9% -4.0%
Rev Growth +1.4% -0.9% -6.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 346.6K 417.6K 399.9K
Total Equity 1.19M 1.15M 1.08M
D/E Ratio 0.29 0.36 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -38,868 -39,496 -31,996
Free Cash Flow -11,585 -14,526 -17,935